Published date: September 09, 2024
Research benefits children in the future but is dependent on patients in the present. Research requires caregivers with children in the PICU to be willing participants during difficult days and nights. Spriggs was a bedside nurse in the PICU before becoming a research coordinator. Her genuine heart and skill with patient care help her maintain the delicate balance between patient families' needs and research goals.
When patients qualify for more than one research study, the team discusses which studies are the highest priority and if the patient can safely participate in more than one study. Research projects fall into two broad categories:
Even with non-interventional studies, patient safety is the most crucial factor. Infants and toddlers have less total blood volume than older children; therefore, less blood is available for blood samples. The research team limits the number of samples by restricting the number of studies a patient participates in. With interventional studies, the team must decide which experimental treatments might benefit the patient. Research coordinators aren't allowed to know if a research participant receives an experimental medication or a placebo. Still, if a new medicine or treatment might help the patient, it becomes a factor when prioritizing.
Many of the 26 active PICU-related research studies ACRI participates in are hosted by other hospitals and research institutions. Arkansas Children's team members developed some of the 26, including a new study examining how white blood cells in the lungs respond to sepsis, a severe reaction to infection. One of the day's qualifying patients could be the first participant in the non-interventional study developed by an attending ACH physician.
"Luckily, we work with great clinicians who are enthusiastic about research," Spriggs said. "We work in a place that's very research positive."
When prioritizing is particularly complicated, like this day, the team consults research director Olivia Irby, M.D., a pediatric critical care medicine physician at ACH and assistant professor in the division of critical care medicine at the University of Arkansas for Medical Sciences.
After consulting with Dr. Irby and the patient’s care team, the research team approached the caregivers about participating in one of the longstanding projects, which rarely has qualifying patients.
Spriggs and a fellow PICU research team member joined Dr. Irby in the patient's room to explain the study, answer questions and provide support. The caregivers are immediately receptive to anything that might help their child. They trust the care provided at ACH. Instead of getting a quick signature, the research team slows the conversation. They want to ensure the caregivers understand the potential risks and that the potential benefits aren't guaranteed. Over the next hour, the caregivers talk more about the joys and frustrations of parenthood than the research project. Once the research team believes the caregivers can make an informed decision, they share the project details.
After caregivers give consent, data collection can begin. ACH has labs and pharmacists dedicated to research studies. Being solely focused on the studies ensures the integrity of the research. Spriggs first contacts the pharmacists if an interventional study involves a new medication, sometimes requiring specialized syringes or containers. Spriggs often recruits PICU nurses if blood samples are needed, thanking them with candy for going above and beyond their regular duties. She regularly provides educational materials on active studies, especially interventional studies, because, she said, "Research wouldn't move forward without help from the bedside staff."
Arkansas Children's is home to around 80 research coordinators across all departments. Research coordinators, like Spriggs, champion children every day by dedicating themselves to work that focuses on making a healthier tomorrow.
Browse open positions